Soru

Zorluk: OrtaPharmacological and Parenteral Therapies

An adult client hospitalized with rapid atrial fibrillation is receiving a continuous intravenous (IV) infusion of diltiazem to maintain ventricular rate control. The client has a single peripheral IV catheter located in the left forearm. The healthcare provider prescribes a scheduled dose of intravenous pantoprazole. The nurse consults the facility's pharmacology reference and notes that pantoprazole is physically incompatible with diltiazem. Which action should the nurse take to safely administer the prescribed medication?

  1. A
    Connect the secondary medication tubing to the Y-site port situated nearest to the client's venous access point.
  2. B
    Temporarily halt the continuous infusion, flush the line with sterile normal saline, administer the medication, flush again, and then resume the continuous infusion.
  3. Insert an additional peripheral intravenous catheter in a different location to infuse the medication independently.Cevap
  4. D
    Mix the prescribed dose of the secondary medication directly into the continuous infusion bag to dilute the concentration over a longer period.

Cevap

The nurse must insert an additional peripheral intravenous catheter in a different location to infuse the medication independently.
When a client is receiving a critical, continuous medication infusion (such as diltiazem for rate control) that cannot be safely paused, and a newly prescribed medication is physically incompatible with that continuous infusion, the nurse must establish a separate intravenous access site. This prevents chemical precipitation from drug incompatibility and ensures the client's hemodynamic stability is not compromised by interrupting the critical continuous drip.

Adım Adım Çözüm

1
Identify the continuous medication being administered and evaluate its clinical purpose.
The client is receiving diltiazem, a critical continuous infusion necessary to control a rapid ventricular rate.
Understanding the necessity of an active infusion determines whether it can be safely paused to administer other treatments.
2
Review the compatibility of the newly prescribed medication with the primary continuous infusion.
The pharmacology reference confirms that pantoprazole is physically incompatible with diltiazem.
Incompatible medications mixed in the same intravenous line can form lethal precipitates, causing emboli, catheter blockages, or chemical inactivation.
3
Determine the safest method to administer both required medications without causing patient harm.
A new, independent peripheral intravenous line must be established for the pantoprazole.
The critical rate-control infusion cannot be paused without risking patient instability, and the incompatible drugs cannot share the same venous access.

Anahtar Kavram

Intravenous Medication Compatibility and Critical Drip Management
Bu soruyu puanla